Home > Income Statement > ERIS LIFESCIENCES

ERIS LIFESCIENCES
Revenue

    Back to Income Statement
ERIS LIFESCIENCES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
AD     Remove this Ad

ERIS LIFESCIENCES Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹2,009 Cr₹16,851 Cr₹1,347 Cr₹1,212 Cr₹1,074 Cr

What is the latest Revenue of ERIS LIFESCIENCES ?

The latest Revenue ratio of ERIS LIFESCIENCES is ₹2,009 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹2,009 Cr
Mar2024₹16,851 Cr
Mar2023₹1,347 Cr
Mar2022₹1,212 Cr
Mar2021₹1,074 Cr

How is Revenue of ERIS LIFESCIENCES Trending?

Years Revenue % Change
Mar2025 ₹2,009 Cr
-88.08
Mar2024 ₹16,851 Cr
1,151.00
Mar2023 ₹1,347 Cr
11.15
Mar2022 ₹1,212 Cr
12.83
Mar2021 ₹1,074 Cr -

Compare Revenue of peers of ERIS LIFESCIENCES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ERIS LIFESCIENCES ₹19,224.5 Cr 5.4% 2.8% 3.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹396,370.0 Cr -3.9% -8.9% -3.2% Stock Analytics
DIVIS LABORATORIES ₹161,193.0 Cr 3.8% -4.7% 11.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹141,438.0 Cr 3.2% -5.6% 26.6% Stock Analytics
DR REDDYS LABORATORIES ₹103,097.0 Cr 3.3% -6% 11% Stock Analytics
CIPLA ₹97,846.7 Cr 0.8% -9.1% -13.1% Stock Analytics


ERIS LIFESCIENCES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
ERIS LIFESCIENCES

5.4%

2.8%

3.8%

SENSEX

3.7%

-0.9%

0.7%


You may also like the below Video Courses